QIAGEN ROA 2010-2023 | QGEN
Current and historical return on assets (ROA) values for QIAGEN (QGEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| QIAGEN ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-03-31 |
$0.35B |
$6.28B |
5.59% |
| 2022-12-31 |
$0.42B |
$6.29B |
6.73% |
| 2022-09-30 |
$0.46B |
$6.52B |
7.41% |
| 2022-06-30 |
$0.51B |
$6.15B |
8.38% |
| 2022-03-31 |
$0.54B |
$6.18B |
8.86% |
| 2021-12-31 |
$0.51B |
$6.15B |
8.58% |
| 2021-09-30 |
$0.60B |
$6.04B |
10.11% |
| 2021-06-30 |
$0.48B |
$5.91B |
8.24% |
| 2021-03-31 |
$0.45B |
$5.76B |
7.91% |
| 2020-12-31 |
$0.36B |
$5.87B |
6.51% |
| 2020-09-30 |
$0.19B |
$5.77B |
3.57% |
| 2020-06-30 |
$0.01B |
$5.30B |
0.27% |
| 2020-03-31 |
$-0.03B |
$5.18B |
-0.59% |
| 2019-12-31 |
$-0.04B |
$5.24B |
-0.77% |
| 2019-09-30 |
$-0.03B |
$5.14B |
-0.46% |
| 2019-06-30 |
$0.20B |
$5.38B |
3.59% |
| 2019-03-31 |
$0.19B |
$5.42B |
3.45% |
| 2018-12-31 |
$0.19B |
$5.75B |
3.54% |
| 2018-09-30 |
$0.09B |
$5.30B |
1.72% |
| 2018-06-30 |
$0.08B |
$5.31B |
1.50% |
| 2018-03-31 |
$0.05B |
$5.11B |
1.09% |
| 2017-12-31 |
$0.04B |
$5.04B |
0.85% |
| 2017-09-30 |
$0.09B |
$5.10B |
1.97% |
| 2017-06-30 |
$0.08B |
$4.56B |
1.76% |
| 2017-03-31 |
$0.08B |
$4.07B |
1.97% |
| 2016-12-31 |
$0.08B |
$4.31B |
1.92% |
| 2016-09-30 |
$0.12B |
$4.33B |
2.96% |
| 2016-06-30 |
$0.12B |
$4.12B |
2.97% |
| 2016-03-31 |
$0.13B |
$4.12B |
3.06% |
| 2015-12-31 |
$0.13B |
$4.18B |
3.13% |
| 2015-09-30 |
$0.10B |
$4.16B |
2.46% |
| 2015-06-30 |
$0.11B |
$4.13B |
2.44% |
| 2015-03-31 |
$0.11B |
$4.17B |
2.56% |
| 2014-12-31 |
$0.12B |
$4.45B |
2.60% |
| 2014-09-30 |
$0.15B |
$4.46B |
3.43% |
| 2014-06-30 |
$0.16B |
$4.56B |
3.65% |
| 2014-03-31 |
$0.07B |
$4.49B |
1.73% |
| 2013-12-31 |
$0.07B |
$4.09B |
1.71% |
| 2013-09-30 |
$0.05B |
$4.06B |
1.16% |
| 2013-06-30 |
$0.04B |
$3.98B |
0.87% |
| 2013-03-31 |
$0.12B |
$4.03B |
3.01% |
| 2012-12-31 |
$0.13B |
$4.09B |
3.28% |
| 2012-09-30 |
$0.09B |
$3.96B |
2.37% |
| 2012-06-30 |
$0.10B |
$3.88B |
2.53% |
| 2012-03-31 |
$0.10B |
$3.80B |
2.51% |
| 2011-12-31 |
$0.10B |
$3.73B |
2.46% |
| 2011-09-30 |
$0.13B |
$3.95B |
3.34% |
| 2011-06-30 |
$0.13B |
$4.00B |
3.38% |
| 2011-03-31 |
$0.14B |
$3.96B |
3.58% |
| 2010-12-31 |
$0.14B |
$3.91B |
3.75% |
| 2010-09-30 |
$0.15B |
$3.89B |
3.99% |
| 2010-06-30 |
$0.15B |
$3.77B |
4.08% |
| 2010-03-31 |
$0.15B |
$3.78B |
4.08% |
| 2009-12-31 |
$0.14B |
$3.80B |
4.13% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.454B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
